Cesar Augusto Santa-Maria, MD

NPI 1134381692ActiveIndividual· Internal Medicine, Medical Oncology· Baltimore, MD

Internal Medicine, Medical Oncology (MD) in Baltimore, Maryland, trained at University of Texas Medical School at Houston (class of 2008). Their prescriptions cost Medicare Part D more than their services did: $357,100 for 183 claims, against $16,941 paid for services in 2024. Astrazeneca Pharmaceuticals LP reported $133.63 in payments in 2025, mostly food and beverage.

Overview

NPI	1134381692
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jun 26, 2008
Last updated in NPPES	Nov 2, 2017

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Medical Oncology Primary	207RX0202X	D72460	MD
Internal Medicine, Medical Oncology	207RX0202X	036135844	IL

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Medical Oncology (DC); Practitioner - Hematology/Oncology (IL); Practitioner - Medical Oncology (MD)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	89
Services billed	192 across 12 procedure codes
Paid by Medicare	$16,941

Part D prescriptions in 2024

Prescriptions (claims)	183 · 352 30-day fills
Patients	55
Total drug cost	$357,100
Generic share	82% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Medical School at Houston
Graduation year	2008
Medicare specialty	Medical Oncology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth